Altered serum transforming growth factor-β1 and monocyte chemoattractant protein-1 levels in obstructive jaundice

World Journal of Surgery

Volumn 28, Issue 10, 2004, Pages 967-970

  Sheen Chen, Shyr Ming ^a   Eng, Hock Liew ^a   Hung, Kuo Sheng ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; DEOXYCHOLIC ACID; GLUTAMINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; BLOOD SAMPLING; CENTRIFUGATION; COMMON BILE DUCT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; OBSTRUCTIVE JAUNDICE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZATION; RAT;

ANIMALS; CHEMOKINE CCL2; JAUNDICE, OBSTRUCTIVE; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 12144267261     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7354-z     Document Type: Article

References (38)

1. Postlethwaite AR, Keski-oja J, Moses HC, et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J. Exp. Med. 1987;165:251
2. Roberts AB, Sporn MD, Associan RK, et al. Transforming growth factor type-β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 1986;83:4167
3. Massague J, Cheifetz S, Endo T, et al. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl. Acad. Sci. USA 1986;83:8206
4. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72 kDa progelatinase, and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor β. J. Biol. Chem. 1988;264:1860
5. Lin P, Liu C, Tsao M, et al. Inhibition of proliferation of cultured rat liver epithelial cells at specific cell cycle stages by transforming growth factor-β. Biochem. Biophys. Res. Commun. 1987;153:26
6. Kurokawa M, Lynch K, Podolsky DK. Effects of growth factors in an intestinal epithelial cell line: transforming growth factor β inhibitors proliferation and stimulates differentiation. Biochem. Biophys. Res. Commun. 1987;142:775
7. Nagy P, Evarts RP, McMahon JB, et al. Role of TGF-β1 in normal differentiation and oncogenesis in rat liver. Mol. Carcinog. 1989;2:345
8. Nakatsukasa H, Nagy P, Evarts RP, et al. Cellular distribution of transforming growth factor-β1 and procollagen types I, III and IV transcript in carbon tetrachloride-induced rat liver fibrosis. J. Clin. Invest. 1990;85:1833
9. Mukaida N, Harada A, Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev. 1998;9:9-23
10. Scott-Conner CEH, Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J. Surg. Res. 1994;57:316-336
11. Pitt HA, Cameron JL, Postier RG, et al. Factors affecting mortality in biliary tract surgery. Am. J. Surg. 1981;141:66-72
12. Su C, Peng FK, Lui WY. Factors affecting morbidity and mortality in biliary tract surgery. World J. Surg. 1992;16:536-540
13. Deitch EA, Sitting K, Berg R, et al. Obstructive jaundice promotes bacterial translocation from the gut. Am. J. Surg. 1990;159:79-84
14. Bossuyt HV, Desmaretz C, Gaeta GB, et al. The role of bile acids in the development of endotoxemia during obstructive jaundice in the rat. J. Hepatol. 1990;10:274-279
15. Sheen-Chen SM, Chau P, Harris HW. Obstructive jaundice alters Kupffer cell function independent of bacterial translocation. J. Surg. Res. 1998;80:205-209
16. Evans HJR, Torreallba V, Hudd C, et al. The effect of preoperative bile salt administration on postoperative renal function in patients with obstructive jaundice. Br. J. Surg. 1982;69:706-708
17. Cahill CJ. Prevention of postoperative renal failure in patients with obstructive jaundice: the role of bile salts. Br. J. Surg. 1983;70:590-595
18. Ding JW, Andersson R, Soltesz V, et al. The role of bile and bile acids in bacterial translocation in obstructive jaundice in rats. Eur. Surg. Res. 1993;25:11-19
19. Bailey ME. Endotoxin, bile salts and renal failure in obstruction jaundice. Br. J. Surg. 1976;63:774-778
20. Floch MH, Gershengoren W, Diamond S, et al. Cholic acid inhibition of intestinal bacteria. Am. J. Clin. Nutr. 1970;23:8-10
21. Williams RC, Showalter R, Kern F. In vivo effect of bile salts and cholestyramine on intestinal anaerobic bacteria. Gastroenterology 1975;69:483-491
22. Grant J. Use of 1-glutamine in total parenteral nutrition. J. Surg. Res. 1988;44:506-513
23. Hwang T, O'Dwye S, Smith R. Preservation of small bowel using glutamine enriched parenteral nutrition. Surg. Forum 1986;37:56-58
24. Sheen-Chen SM, Chen HS, Ho HT, et al. Effect of bile acid replacement on endotoxin-induced tumor necrosis factor-alpha production in obstructive jaundice. World J. Surg. 2002;26:448-450
25. Sheen-Chen SM, Ho HT, Chen WJ, et al. Obstructive jaundice alters CD44 expression in rat small intestine. Digestion 2002;65:112-117
26. Sheen-Chen SM, Ho HT, Chen WJ, et al. Obstructive jaundice alters proliferating cell nuclear antigen expression in rat small intestine. World J. Surg. 2003;27:1161-1164
27. Sheen-Chen SM, Chen HS, Ho HT, et al. Obstructive jaundice alters LFA-1a expression in rat small intestine. Dig. Dis. Sci. 2003;48:1165-1170
28. Russell WE, Coffey RJ, Ouellette AJ, et al. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc. Natl. Acad. Sci. USA 1988;85:5126-5130
29. Russell WE. Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation. J. Cell. Physiol. 1988;135:253-261
30. Ponchel F, Puisieux A, Tabone E, et al. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res. 1994;54:2064-2068
31. Meert KL, Ofenstein JP, Genyea C, et al. Elevated transforming growth factor-beta concentration correlates with posttrauma immunosuppression. J. Trauma 1996;40:901-906
32. Nishimura T, Nishiura T, deSerres S, et al. Impact of burn injury on hepatic TGF-β1 expression and plasma TGF-β1 levels. J. Trauma 2000;48:39-44
33. Heys SD, Ashkanani F. Glutamine. Br. J. Surg. 1999;86:289-290
34. Heys SD, Gough DB, Khan L, et al. Nutritional pharmacology and malignant disease: a therapeutic modality in patients with cancer? Br. J. Surg. 1996;83:608-619
35. Chensue SW, Warmington KS, Ruth JH, et al. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation. J. Immunol. 1996;157:4602-4608
36. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunology 1990;11:97-101
37. Sylvester I, Suffredini AF, Boujoukos GD, et al. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum. J. Immunol. 1993;151:3292-3298
38. Bossink AWJ, Paemen PM, Jansen CE, et al. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 1995;86:3841-3847